Optimizing BTKi Treatment Strategies
The panelists provide perspectives on critical aspects of the CLL and SLL treatment landscape.
Stay updated with breaking news from Cart Therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The panelists provide perspectives on critical aspects of the CLL and SLL treatment landscape.
Medical experts provide their final thoughts regarding key treatment considerations for CLL and SLL.
Gabriel Hinojosa, PharmD, BCOP, explores unmet needs and social determinants in multiple myeloma care, envisioning treatment advancements amid evolving complexities and patient disparities.
Faculty offer insights on the NEXICART-1 phase 1 clinical trial investigating the safety and efficacy of NXC-201 in patients with AL amyloidosis and discuss potential clinical implications on the study’s findings.
Heather Landau, MD, invites panelists to provide their insights on the future outlook for the treatment of AL amyloidosis.